Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Preventing group B streptococcal infections: new recommendations.

Literature DB >> 18159394

Preventing group B streptococcal infections: new recommendations.

H Dele Davies¹.

Abstract

Entities: Disease

Year: 2002 PMID： 18159394 PMCID： PMC2094877 DOI： 10.1155/2002/352613

Source DB: PubMed Journal: Can J Infect Dis ISSN： 1180-2332

× No keyword cloud information.

50 in total

1. Antibodies to capsular polysaccharides of group B Streptococcus in pregnant Canadian women: relationship to colonization status and infection in the neonate.

Authors: H D Davies; C Adair; A McGeer; D Ma; S Robertson; M Mucenski; L Kowalsky; G Tyrell; C J Baker
Journal: J Infect Dis Date: 2001-06-26 Impact factor: 5.226

2. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis.

Authors: S J Schrag; S Zywicki; M M Farley; A L Reingold; L H Harrison; L B Lefkowitz; J L Hadler; R Danila; P R Cieslak; A Schuchat
Journal: N Engl J Med Date: 2000-01-06 Impact factor: 91.245

Review 3. Strategies for the prevention of early-onset neonatal group B streptococcal sepsis: a decision analysis.

Authors: D J Rouse; R L Goldenberg; S P Cliver; G R Cutter; S T Mennemeyer; C A Fargason
Journal: Obstet Gynecol Date: 1994-04 Impact factor: 7.661

4. The epidemiology of group B streptococcal colonization in pregnancy. Vaginal Infections and Prematurity Study Group.

Authors: J A Regan; M A Klebanoff; R P Nugent
Journal: Obstet Gynecol Date: 1991-04 Impact factor: 7.661

5. Antibiotic susceptibility profiles for group B streptococci isolated from neonates, 1995-1998.

Authors: F Y Lin; P H Azimi; L E Weisman; J B Philips; J Regan; P Clark; G G Rhoads; J Clemens; J Troendle; E Pratt; R A Brenner; V Gill
Journal: Clin Infect Dis Date: 2000-07-24 Impact factor: 9.079

6. Potential consequences of widespread antepartal use of ampicillin.

Authors: C V Towers; M H Carr; G Padilla; T Asrat
Journal: Am J Obstet Gynecol Date: 1998-10 Impact factor: 8.661

7. Multistate case-control study of maternal risk factors for neonatal group B streptococcal disease. The Active Surveillance Study Group.

Authors: A Schuchat; K Deaver-Robinson; B D Plikaytis; K M Zangwill; J Mohle-Boetani; J D Wenger
Journal: Pediatr Infect Dis J Date: 1994-07 Impact factor: 2.129

Preventing group B streptococcal infections: new recommendations.

1. Antibodies to capsular polysaccharides of group B Streptococcus in pregnant Canadian women: relationship to colonization status and infection in the neonate.

2. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis.

Review 3. Strategies for the prevention of early-onset neonatal group B streptococcal sepsis: a decision analysis.

4. The epidemiology of group B streptococcal colonization in pregnancy. Vaginal Infections and Prematurity Study Group.

5. Antibiotic susceptibility profiles for group B streptococci isolated from neonates, 1995-1998.

6. Potential consequences of widespread antepartal use of ampicillin.

7. Multistate case-control study of maternal risk factors for neonatal group B streptococcal disease. The Active Surveillance Study Group.

8. Early-onset group B streptococcal sepsis: a current assessment.

9. Perinatal group B streptococcal colonization and infection.

10. Group B streptococcal infections in pregnancy. ACOG Technical Bulletin Number 170--July 1992.

1. Epidemiological Characterization of Group B Streptococcus Infections in Alberta, Canada: An Update from 2014 to 2020.